RushNet, Inc. Announces Appointment of Frank Deangelo as CEO
July 20, 2018 at 10:00 am EDT
Share
RushNet, Inc. announced that Richard Goulding, MD, appointed Frank Deangelo as the Chief Executive Officer of RushNet, Inc. Mr. Deangelo is the retired President and CEO of Applejam, Inc. Dr. Goulding will continue to also serve in his roles as Chairman of the Board of Directors and Chief Medical Officer.
RushNet, Inc. operates under the name HeliosDX. HeliosDX is a national clinical reference laboratory offering high-complexity urine drug testing (UDT), behavioral drug testing, allergy droplet cards, oral fluids, and infectious disease (PCR). The Company provides management services and insurance billing services principally to clinical reference laboratories. It provides PGX testing through Leo Partners. It provides oral fluid toxicology testing for a range of drugs. The Quantisal Collection Procedure makes taking the sample quick and easy. HeliosDX also offers a preliminary 10-panel plus adulteration detection screen, as well as confirmation testing via its comprehensive toxicology panel. Its subsidiaries include Chattahoochee Physicians Laboratory Services, LLC; doing business as HeliosDx and Grandeza Healthcare Consultants, LLC.
RUSHNET, INC. 
